Epigral Ltd. (EPIGRAL) - Net Assets

Latest as of March 2026: Rs22.21 Billion INR ≈ $240.24 Million USD

Based on the latest financial reports, Epigral Ltd. (EPIGRAL) has net assets worth Rs22.21 Billion INR (≈ $240.24 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs35.05 Billion ≈ $379.08 Million USD) and total liabilities (Rs12.84 Billion ≈ $138.85 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See Epigral Ltd. (EPIGRAL) balance sheet quality index to measure how much of total assets are equity-financed.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs22.21 Billion
% of Total Assets	63.37%
Annual Growth Rate	23.38%
5-Year Change	205.99%
10-Year Change	514.13%
Growth Volatility	16.79

Epigral Ltd. - Net Assets Trend (2015–2026)

This chart illustrates how Epigral Ltd.'s net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Epigral Ltd. market capitalisation.

Annual Net Assets for Epigral Ltd. (2015–2026)

The table below shows the annual net assets of Epigral Ltd. from 2015 to 2026. Also explore Epigral Ltd. annual equity growth to track the company's year-over-year net asset growth rate.

Year	Net Assets	Change
2026-03-31	Rs22.21 Billion ≈ $240.24 Million	+16.64%
2025-03-31	Rs19.05 Billion ≈ $205.97 Million	+51.86%
2024-03-31	Rs12.54 Billion ≈ $135.63 Million	+17.30%
2023-03-31	Rs10.69 Billion ≈ $115.62 Million	+47.27%
2022-03-31	Rs7.26 Billion ≈ $78.51 Million	+6.12%
2021-03-31	Rs6.84 Billion ≈ $73.99 Million	+17.25%
2020-03-31	Rs5.83 Billion ≈ $63.10 Million	+18.41%
2019-03-31	Rs4.93 Billion ≈ $53.29 Million	-4.75%
2018-03-31	Rs5.17 Billion ≈ $55.95 Million	+43.02%
2017-03-31	Rs3.62 Billion ≈ $39.12 Million	+22.56%
2016-03-31	Rs2.95 Billion ≈ $31.92 Million	+34.01%
2015-03-31	Rs2.20 Billion ≈ $23.82 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Epigral Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 25988.6% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2026)

Component	Amount	Percentage
Retained Earnings	Rs21.02 Billion	94.62%
Common Stock	Rs431.40 Million	1.94%
Other Comprehensive Income	Rs-2.47 Billion	-11.10%
Other Components	Rs3.23 Billion	14.55%
Total Equity	Rs22.21 Billion	100.00%

Epigral Ltd. Competitors by Market Cap

The table below lists competitors of Epigral Ltd. ranked by their market capitalization.

Company	Market Cap
Veradigm Inc. NASDAQ:MDRX	$515.71 Million
Anhui Xinli Finance Co Ltd SHG:600318	$516.19 Million
GS P&L CO LTD KO:499790	$516.20 Million
Zhenhai PetroChem Engineering SHG:603637	$516.22 Million
Velesto Energy Bhd KLSE:5243	$515.67 Million
4D Molecular Therapeutics Inc NASDAQ:FDMT	$515.62 Million
Invesco Quality Municipal Income Closed Fund NYSE:IQI	$515.62 Million
Anglo American PLC LSE:AAL	$515.61 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Epigral Ltd.'s equity between the two most recent reporting periods.

Equity Growth Insights

From 2025 to 2026, total equity changed from 19,045,300,000 to 22,214,300,000, a change of 3,169,000,000 (16.6%).
Net income of 3,319,700,000 contributed positively to equity growth.
Dividend payments of 183,200,000 reduced retained earnings.

Equity Change Factors (2025 to 2026)

Factor	Impact	Contribution
Net Income	Rs3.32 Billion	+14.94%
Dividends Paid	Rs183.20 Million	-0.82%
Other Changes	Rs32.50 Million	+0.15%
Total Change	Rs-	16.64%

Book Value vs Market Value Analysis

This analysis compares Epigral Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.15x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 35.51x to 2.15x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2015-03-31	Rs31.12	Rs1105.30	x
2016-03-31	Rs41.71	Rs1105.30	x
2017-03-31	Rs51.12	Rs1105.30	x
2018-03-31	Rs124.51	Rs1105.30	x
2019-03-31	Rs118.60	Rs1105.30	x
2020-03-31	Rs100.48	Rs1105.30	x
2021-03-31	Rs117.09	Rs1105.30	x
2022-03-31	Rs174.72	Rs1105.30	x
2023-03-31	Rs257.30	Rs1105.30	x
2024-03-31	Rs301.83	Rs1105.30	x
2025-03-31	Rs450.88	Rs1105.30	x
2026-03-31	Rs514.92	Rs1105.30	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Epigral Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 14.94%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 13.30%
• Asset Turnover: 0.71x
• Equity Multiplier: 1.58x
Recent ROE (14.94%) is below the historical average (22.93%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2015	15.75%	9.86%	0.66x	2.43x	Rs126.61 Million
2016	22.76%	16.87%	0.74x	1.83x	Rs376.67 Million
2017	18.40%	16.97%	0.74x	1.46x	Rs303.68 Million
2018	30.05%	26.04%	0.89x	1.30x	Rs1.04 Billion
2019	37.10%	25.74%	0.68x	2.12x	Rs1.34 Billion
2020	19.20%	18.36%	0.48x	2.18x	Rs536.51 Million
2021	14.74%	12.21%	0.57x	2.12x	Rs324.26 Million
2022	34.82%	16.31%	0.73x	2.93x	Rs1.80 Billion
2023	33.05%	16.28%	0.89x	2.28x	Rs2.46 Billion
2024	15.62%	10.34%	0.68x	2.23x	Rs704.56 Million
2025	18.78%	14.03%	0.81x	1.66x	Rs1.67 Billion
2026	14.94%	13.30%	0.71x	1.58x	Rs1.10 Billion

Industry Comparison

This section compares Epigral Ltd.'s net assets metrics with peer companies in the Chemicals industry.

Industry Context

Industry: Chemicals
Average net assets among peers: $11,816,906,548
Average return on equity (ROE) among peers: 11.01%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Epigral Ltd. (EPIGRAL)	Rs22.21 Billion	15.75%	0.58x	$515.69 Million
Archean Chemical Industries Limited (ACI)	$17.02 Billion	18.75%	0.21x	$623.72 Million
The Andhra Sugars Limited (ANDHRSUGAR)	$16.37 Billion	11.36%	0.24x	$137.93 Million
Bhansali Engineering Polymers Limited (BEPL)	$2.00 Billion	-5.72%	0.98x	$347.04 Million
Chemplast Sanmar Limited (CHEMPLASTS)	$4.98 Billion	35.86%	4.35x	$293.21 Million
DCW Limited (DCW)	$6.32 Billion	-0.68%	1.88x	$170.47 Million
Deepak Fertilizers and Petrochemicals Corporation Limited (DEEPAKFERT)	$54.46 Billion	8.13%	1.17x	$1.83 Billion
DIAMINES AND CHEMICALS ORD (BSE) (DIAMINESQ)	$343.20 Million	1.13%	0.88x	$27.92 Million
DMCC SPECIALITY CHEMICALS LIMITED (DMCC)	$2.48 Billion	11.01%	0.80x	$75.70 Million
Foseco India Limited (FOSECOIND)	$2.39 Billion	19.23%	0.44x	$544.30 Million

About Epigral Ltd.

NSE:EPIGRAL India Chemicals

Market Cap

$515.69 Million

Rs47.68 Billion INR

Market Cap Rank

#12201 Global

#617 in India

Share Price

Rs1105.30

Change (1 day)

+0.35%

52-Week Range

Rs810.45 - Rs1753.70

All Time High

Rs2344.35